Reference publications
Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 Update.
DeTora LM, Toroser D, Sykes A, Vanderlinden C, Plunkett FJ, Lane T, Hanekamp E, Dormer L, DiBiasi F, Bridges D, Baltzer L, Citrome, L. Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 Update.
Annals of Internal Medicine 2022;175, 1298–1304. https://doi.org/10.7326/M22-1460
Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP3
Battisti WP, Wager E, Baltzer L, Bridges D, Cairns A, Carswell CI, Citrome L, Gurr JA, Mooney LA, Moore BJ, Peña T, Sanes-Miller CH, Veitch K, Woolley KL, Yarker YE. Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP3. Annals of Internal Medicine 2015;163: 461–464. https://doi.org/10.7326/M15-0288
Background (ISMPP research and articles, only available to ISMPP members at this time)
Example of objective congress abstract selection criteria:
Kuczmarski TM, Raja AS, Pallin DJ. How do Medical Societies Select Science for Conference Presentation? How Should They? West J Emerg Med. 2015;16(4):543-550. doi:10.5811/westjem.2015.5.25518
Why the pharmaceutical industry needs clarity and guidance around encore presentations:
Ramchandren R, Schiffer CA, Ramchandren R, Schiffer CA. ReCAP: Pattern of Duplicate Presentations at National Hematology-Oncology Meetings: Influence of the Pharmaceutical Industry. J Oncol Pract. 2016;12(3):252-253. doi:10.1200/JOP.2015.004523
Conflict of interest reporting for oral presentations is confusing and inconsistent:
Grey A, Avenell A, Dalbeth N, Stewart F, Bolland MJ. Reporting of conflicts of interest in oral presentations at medical conferences: a delegate-based prospective observational study. BMJ Open. 2017;7(9):e017019. doi:10.1136/bmjopen-2017-017019
Conference recordings do not constitute prior publications COPE case 18-10: An editor received a query from an author: “Your guidelines are clear that presenting data at a society meeting does not preclude publication. But what if the society records the presentation, retains copyright of that recording, and posts it online? Is asking presenters to turn over copyright of a recording of data presented at a prepublication stage and disseminating the recording as they see fit crossing the "prior publication" line?”
Short answer... no
DeTora LM, Toroser D, Sykes A, Vanderlinden C, Plunkett FJ, Lane T, Hanekamp E, Dormer L, DiBiasi F, Bridges D, Baltzer L, Citrome, L. Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 Update.
Annals of Internal Medicine 2022;175, 1298–1304. https://doi.org/10.7326/M22-1460
Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP3
Battisti WP, Wager E, Baltzer L, Bridges D, Cairns A, Carswell CI, Citrome L, Gurr JA, Mooney LA, Moore BJ, Peña T, Sanes-Miller CH, Veitch K, Woolley KL, Yarker YE. Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP3. Annals of Internal Medicine 2015;163: 461–464. https://doi.org/10.7326/M15-0288
- GPP3 FAQ page can be accessed here
Background (ISMPP research and articles, only available to ISMPP members at this time)
- Panayi A, Wiehn J, Wieting S, Elsner A, Baronikova S, Marchington J, Rains C. A survey of current practices in encore abstract submissions from industry- sponsored study data. Current Medical Research and Opinion 2014;30 Sup 1: S20.
- Slides can be accessed here (pages 19-38)
- Ayo-Okanlawon K, MacLucas A, Kennard NC. Is there a need for uniform poster presentation guidelines across conferences? Current Medical Research and Opinion 2016;32 Sup 1: S16.
- Poster can be accessed here (ISMPP login required)
- Baum E, Ma H. (2018). Encore vs. Original Presentations: Black, White, and Shades of Gray. The MAP https://ismpp-newsletter.com/2018/08/13/encore-vs-original-presentations-black-white-and-shades-of-gray/
Example of objective congress abstract selection criteria:
Kuczmarski TM, Raja AS, Pallin DJ. How do Medical Societies Select Science for Conference Presentation? How Should They? West J Emerg Med. 2015;16(4):543-550. doi:10.5811/westjem.2015.5.25518
Why the pharmaceutical industry needs clarity and guidance around encore presentations:
Ramchandren R, Schiffer CA, Ramchandren R, Schiffer CA. ReCAP: Pattern of Duplicate Presentations at National Hematology-Oncology Meetings: Influence of the Pharmaceutical Industry. J Oncol Pract. 2016;12(3):252-253. doi:10.1200/JOP.2015.004523
Conflict of interest reporting for oral presentations is confusing and inconsistent:
Grey A, Avenell A, Dalbeth N, Stewart F, Bolland MJ. Reporting of conflicts of interest in oral presentations at medical conferences: a delegate-based prospective observational study. BMJ Open. 2017;7(9):e017019. doi:10.1136/bmjopen-2017-017019
Conference recordings do not constitute prior publications COPE case 18-10: An editor received a query from an author: “Your guidelines are clear that presenting data at a society meeting does not preclude publication. But what if the society records the presentation, retains copyright of that recording, and posts it online? Is asking presenters to turn over copyright of a recording of data presented at a prepublication stage and disseminating the recording as they see fit crossing the "prior publication" line?”
Short answer... no
Presentation resources
It's beyond the remit of these recommendations to guide people on how to prepare abstracts, posters or presentations, but here are some resources that you might find useful:
- Fraser J, Fuller L, Hutber G. Creating effective conference abstracts and posters in biomedicine : 500 tips for success. 2009. Radcliffe Pub. Link to buy
- Designing conference posters: https://colinpurrington.com/tips/poster-design
- Growing school of thought on minimalist posters and key take home points. Watch the video or follow the hashtag #betterposter